ALSO READAurobindo Pharma acquires Portuguese pharma company - Generis Farmaceutica S.A. Aurobindo Pharma fixes record date for second interim dividend Aurobindo Pharma gets final approval for Abacavir Sulfate and Lamivudine Tablets Aurobindo Pharma gets USFDA nod to market kidney ailment drug Aurobindo Pharma jumps over 8% on USFDA nod
Increasing its stake in Tergene Biotech from 60% to 80%Aurobindo Pharma announced that Tergene Biotech is a 60:40 joint venture between the Company and promoters of Tergene.
As agreed among the JV Partners, the Company will increase its stake in Tergene Biotech from 60% to 80% by subscribing additional 56,50,000 equity shares of Rs.10 each at par aggregating to Rs.5.65 crore.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)